New drug tested as last hope for aggressive brain cancer
Disease control
Terminated
This study tested an experimental drug called VAL-083 for adults with glioblastoma, a fast-growing brain cancer that had returned after standard treatments failed. It compared VAL-083 against a doctor's choice of other approved chemotherapy drugs to see which helped patients live…
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC